T1	Procedure 6 18	chemotherapy
T2	Temporal 0 5	Prior
T3	Line 0 18	Prior chemotherapy
T4	Procedure 25 34	treatment
T5	Drug 40 49	gefitinib
T6	Temporal 19 24	Prior
R2	Has_temporal Arg1:T4 Arg2:T6	
R3	Has_temporal Arg1:T1 Arg2:T2	
T8	Drug 51 60	erlotinib
T7	Drug 71 93	drugs that target EGFR
*	OR T5 T8 T7
T9	Scope 40 93	gefitinib, erlotinib, or other drugs that target EGFR
R1	Has_scope Arg1:T4 Arg2:T9	
T10	Line 19 93	Prior treatment with gefitinib, erlotinib, or other drugs that target EGFR
T11	Post-eligibility 94 157	Patients must not be receiving any other investigational agents
T12	Condition 174 199	interstitial lung disease
